Related Experiment Video
Updated: Nov 1, 2025

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
The functional reach test in people with multiple sclerosis: a reliability and validity study.
Fatih Soke1, Sefa Eldemir2, Taskin Ozkan3
1Gulhane Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Gulhane Saglik Bilimleri Fakultesi (Gulhane Kulliyesi), University of Health Sciences, Ankara, Turkey.
The functional reach test (FRT) reliably assesses limits of stability (LOS) in multiple sclerosis (MS) patients. This simple test is a valid tool for measuring balance dysfunction in MS, distinguishing patients from healthy individuals.
Area of Science:
- Neurology
- Rehabilitation Science
- Biomedical Engineering
Background:
- Limits of stability (LOS) is crucial for balance in multiple sclerosis (MS).
- The functional reach test (FRT) is a clinical LOS assessment tool.
- Psychometric properties of the FRT in MS are not well-established.
Purpose of the Study:
- Assess intrarater, interrater, and test-retest reliability of the FRT in MS patients.
- Determine the minimum detectable change (MDC) for FRT measurements.
- Evaluate concurrent and discriminant validity of the FRT.
- Identify a cutoff distance to differentiate MS patients from healthy individuals and fallers from non-fallers within the MS group.
Main Methods:
- 43 MS patients and 36 healthy controls participated.
- FRT was administered alongside other balance and disability measures.
- Reliability was assessed through repeated measures by the same rater, different raters, and at different time points.
- Validity was examined by correlating FRT with other measures and comparing group differences.
Main Results:
- FRT demonstrated good to excellent reliability (ICC 0.80-0.97).
- Minimum detectable change (MDC) was 8.28 cm.
- FRT showed significant correlation with other outcome measures (r=0.31-0.79).
- A cutoff of 35.5 cm distinguished MS patients from healthy individuals; 28.5 cm did not differentiate fallers from non-fallers in MS.
Conclusions:
- The FRT is a reliable and valid tool for assessing LOS in people with MS.
- Its ease of administration makes it practical for clinical use.
- FRT can effectively differentiate individuals with MS from healthy controls.
More Related Videos
08:48Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis
Published on: January 29, 2016
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019